Industrial insect farming

Industrial insect farming scales black soldier fly (Hermetia illucens) and mealworm (Tenebrio molitor) bioconversion into protein meal, lipids and frass fertilizer for feed and pet-food markets. The sector built one of the largest capital bets in the alternative-protein space over the past decade and is now working through a hard correction: Ynsect, which raised over €500 million and built one of the world’s largest insect plants under its FARMYNG project, was reported in January 2026 to have collapsed into insolvency after over-scaling ahead of demand. In North America, Aspire Food Group’s cricket-protein plant in London, Ontario — billed as the world’s largest cricket farm and backed by tens of millions of dollars in government funding — was placed into receivership reportedly owing C$41.5 million. Not every player is retrenching: InnovaFeed raised a fresh €51 million in 2026 to move to commercial scale while trimming R&D spend, Protix redirected its international expansion from a stalled US joint venture with Tyson Foods toward Asia, and India’s Loopworm reports cutting biologics-grade production costs by up to 80% versus conventional methods while targeting ten-fold growth into salmon and tuna feed markets.

Key directions of industrial insect farming:

1. Black soldier fly bioconversion (Black Soldier Fly Bioconversion): Hermetia illucens larvae processing food waste or agri-residues into protein meal, lipids rich in lauric acid, and frass fertilizer.
2. Mealworm protein platforms (Mealworm Protein Platforms): Tenebrio molitor farmed at industrial scale for protein meal and lipid fractions, the segment where the sector’s largest capital losses have concentrated.
3. Capital-efficient regional entrants (Capital-Efficient Regional Entrants): newer, smaller-capex operators (e.g., in India) targeting specific high-value feed niches (aquafeed) rather than replicating the billion-euro flagship-plant model.
4. Post-overbuild consolidation (Post-Overbuild Consolidation): surviving players pivoting toward leaner operations, cost trims and geographic reallocation (Europe/Asia) rather than continued flagship-scale capital expansion.

Sectoral value chain#

[substrate sourcing] ──> [larval rearing] ──> [processing & separation] ──> [meal/lipid/frass output]
                                                      │
                                              (feed-safety
                                               certification)
                                                      │
                                                      ▼
[aquafeed/petfood sale] <─── [commercial offtake] <───┘

Value chain levels#

Cross-cutting technologies of the sector:

• Automated larval-rearing systems (Automated Larval-Rearing Systems): vertically stacked, sensor-monitored rearing infrastructure designed for continuous-flow, high-volume production.
• Lipid fractionation for lauric acid (Lipid Fractionation for Lauric Acid): separating insect fat into a lauric-acid-rich fraction marketed for piglet gut health and antimicrobial effects.
• Frass fertilizer valorization (Frass Fertilizer Valorization): converting the larval processing byproduct into a marketable organic fertilizer stream alongside the core protein product.

The stack is defined as much by cost/scale engineering as by biology.

1. Vertically stacked automated rearing (Vertically Stacked Automated Rearing):
   • larval-rearing infrastructure is designed for continuous-flow, high-density production to justify large capital plants.
   • case: Ynsect’s FARMYNG plant was built as one of the world’s largest insect-farming facilities on this model before its reported 2026 collapse.
2. Lauric-acid lipid fractionation (Lauric-Acid Lipid Fractionation):
   • insect fat is separated into a lauric-acid-rich fraction specifically marketed for piglet gut health.
   • case: Protix continues to supply lipid fractions for pig-feed applications even as it redirects its geographic expansion.
3. Cost-per-unit biologics engineering (Cost-Per-Unit Biologics Engineering):
   • smaller entrants optimize unit production cost rather than replicating flagship-plant capital intensity.
   • case: Loopworm reports cutting biologics-grade production costs by up to 80% versus conventional methods, underpinning a targeted ten-fold growth plan into aquafeed markets.